当前位置:Public Access >页面
Chinese/English
A multicenter, randomized controlled trial of tamibarotene (OMS0728) in relapsed or refractory acute promyelocytic leukemia (APL).
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。